Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Histopathology|July 21, 2009
Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTsOlga Martinho, António Gouveia, Marta Viana-Pereira, et al.
Melanoma Research|December 29, 2015
Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomasVinicius de Lima Vazquez, Anna L Vicente, Adriana Carloni, et al.
Investigational New Drugs|February 2, 2019
Modified ingenol semi-synthetic derivatives from Euphorbia tirucalli induce cytotoxicity on a large panel of human cancer cell linesViviane A O Silva, Marcela N Rosa, Olga Martinho, et al.
Oncotarget|September 9, 2017
AKT can modulate the <i>in vitro</i> response of HNSCC cells to irreversible EGFR inhibitorsRenato José Silva-Oliveira, Matias Melendez, Olga Martinho, et al.
Translational Oncology|April 2, 2013
In Vitro and In Vivo Analysis of RTK Inhibitor Efficacy and Identification of Its Novel Targets in GlioblastomasOlga Martinho, Renato Silva-Oliveira, Vera Miranda-Gonçalves, et al.
Molecular Carcinogenesis|August 2, 2017
Monocarboxylate transporter 1 is a key player in glioma-endothelial cell crosstalkVera Miranda-Gonçalves, Filipa Bezerra, Raquel Costa-Almeida, et al.
Cells|February 26, 2020
WNK2 Inhibits Autophagic Flux in Human Glioblastoma Cell LineAna Laura Vieira Alves, Angela Margarida Costa, Olga Martinho, et al.
Cells|July 26, 2024
Correction: Alves et al. WNK2 Inhibits Autophagic Flux in Human Glioblastoma Cell Line. <i>Cells</i> 2020, <i>9</i>, 485Ana Laura Vieira Alves, Angela Margarida Costa, Olga Martinho, et al.
Oncotarget|December 22, 2017
Metabolic alterations underlying Bevacizumab therapy in glioblastoma cellsVera Miranda-Gonçalves, Diana Cardoso-Carneiro, Inês Valbom, et al.
Pageof 6